Join us for Market Access 201 as we explore the evolving reimbursement landscape in Canada, and discuss how patient access may be impacted by an increasingly uncertain reimbursement environment.
DIA’s Global Annual Meeting (DIA 2019) gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries to advance innovation in healthcare product development and lifecycle management globally.
Canada’s premier forum on navigating market entry and developing effective pricing strategies.
Reimbursement and Access 2019 arms attendees with invaluable learning, practical strategies and tangible takeaways on the most impactful ways to reduce barriers to access.
Regulatory Convergence is the only conference focused exclusively on regulatory for the healthcare products industry. Find new ways to examine and solve regulatory challenges, network with the best regulatory professionals in the world, and get the latest, most up-to-date industry.
The FT Pharma Pricing and Value Summit will explore the future of drug pricing from a balanced perspective.
CBIs 4th Annual Outcomes-Based Contracting Summit delivers key insights into the process of outlining, structuring and negotiating successful performance and value-based contracts.
PAGE represents a community with a shared interest in data analysis using the population approach.
ASCO provides exemplary education and resources to support oncology practices and promote the delivery of high-quality, high-value cancer care.
With the recent interim report of the governments panel on pharmacare and the budget announcement of a new Canadian Drug Agency, there are plenty of questions about how best to ensure affordable and comprehensive coverage for Canadians. To begin to answer these questions, the Macdonald-Laurier Institute has assembled a top-level panel of...
The ISPOR US meeting features a comprehensive scientific program which will address vital questions on topics including rapid advances in information technology, medical technology, and targeted pharmaceuticals combined with transformations in regulatory decision making, health insurance, payment and delivery systems.
The EMWA spring and autumn conferences provide a medium for networking, active discussions and extensive cost-effective professional training. It is also an opportunity to benefit from the experiences of other medical writers.